US2005202517A1PendingUtilityA1
Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
Priority: Oct 26, 1998Filed: Apr 26, 2005Published: Sep 15, 2005
Est. expiryOct 26, 2018(expired)· nominal 20-yr term from priority
G01N 33/5758G01N 33/6872G01N 2333/4704
32
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An anti-NAIP monoclonal antibody recognizing a human apoptosis inhibitory protein NAIP having the amino acid sequence of SEQ ID NO: 1, which is produced from hybridoma prepared by fusing a myeloma cell line with antibody-producing cell of mammal immunized by antigen containing a polypeptide which comprises amino acid sequence of the 256-586th, the 841-1052nd or parts thereof in SEQ ID NO: 1, NAIP assay method using the antibody, and NAIP assay kits.
Claims
exact text as granted — not AI-modified1 . An anti-NAIP monoclonal antibody, recognizing a human apoptosis inhibitory protein NAIP having the amino acid sequence of SEQ ID NO: 1, which is produced from a hybridoma prepared by fusing a myeloma cell line with an antibody-producing cell of a mammal immunized by an antigen containing a polypeptide which comprises the amino acid sequence of the 256-586th amino acids, the 841-1052nd amino acids, or parts thereof of SEQ ID NO: 1, and wherein the epitope of the anti-NAIP monoclonal antibody is in the amino acid sequence of the 256-586th amino acids, or the 841-1052nd amino acids, of SEQ ID NO: 1.
2 - 11 . (canceled)
12 . A NAIP assay kit comprising:
(a) a plate on which an anti-NAIP primary antibody is immobilized; and (b) an anti-NAIP secondary antibody labeled with a marker, wherein: (1) the primary antibody and the secondary antibody are both the anti-NAIP monoclonal antibody of claim 1 , wherein:
(i) the primary antibody recognizes the amino acid sequence of the 256-585th amino acids of SEQ ID NO: 1 and the secondary antibody recognizes the amino acid sequence of the 841-1052nd amino acids of SEQ ID NO: 1; or
(ii) the primary antibody recognizes the amino acid sequence of the 841-1052nd amino acids of SEQ ID NO: 1 and the secondary antibody recognizes the amino acid sequence of the 256-585th amino acids of SEQ ID NO: 1; or
(2) the primary antibody is the anti-NAIP monoclonal antibody of claim 1 , which recognizes the amino acid sequence of the 256-585th amino acids or the 841-1052nd amino acids of SEQ ID NO: 1 and the secondary antibody is an anti-NAIP polyclonal antibody; or (3) the primary antibody is an anti-NAIP polyclonal antibody and the secondary antibody is the anti-NAIP monoclonal antibody of claim 1 , which recognizes the amino acid sequence of the 256-585th amino acids or the 841-1052nd amino acids of SEQ ID NO: 1.
13 . (canceled)
14 . The NAIP assay kit of claim 12 , wherein the marker is a radioactive isotope or a fluorescent colorant.
15 . The NAIP assaying kit of claim 12 , wherein the marker is an enzyme and the kit further includes a substrate which develops a color by the enzyme activity.
16 . A NAIP assaying kit comprising:
(a) a plate on which an anti-NAIP primary antibody is immobilized; (b) an anti-NAIP secondary antibody; and (c) a marker to be bound with the secondary antibody, wherein: (1) the primary antibody and the secondary antibody are both the anti-NAIP monoclonal antibody of claim 1 , wherein:
(i) the primary antibody recognizes the amino acid sequence of the 256-585th amino acids of SEQ ID NO: 1 and the secondary antibody recognizes the amino acid sequence of the 841-1052nd amino acids of SEQ ID NO: 1; or
(ii) the primary antibody recognizes the amino acid sequence of the 841-1052nd amino acids of SEQ ID NO: 1 and the secondary antibody recognizes the amino acid sequence of the 256-585th amino acids of SEQ ID NO: 1; or
(2) the primary antibody is the anti-NAIP monoclonal antibody of claim 1 , which recognizes the amino acid sequence of the 256-585th amino acids or the 841-1052nd amino acids of SEQ ID NO: 1 and the secondary antibody is an anti-NAIP polyclonal antibody; or (3) the primary antibody is an anti-NAIP polyclonal antibody and the secondary antibody is the anti-NAIP monoclonal antibody of claim 1 , which recognizes the amino acid sequence of the 256-585th amino acids or the 841-1052nd amino acids of SEQ ID NO: 1.
17 . (canceled)
18 . The NAIP assaying kit of claim 16 , wherein the marker is a radioactive isotope or a fluorescent colorant.
19 . The NAIP assaying kit of claim 16 , wherein the marker is an enzyme and the kit further includes a substrate which develops a color by the enzyme activity.Join the waitlist — get patent alerts
Track US2005202517A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.